Anti-SORT/ SORT1/ Gp95 monoclonal antibody

Anti-SORT/ SORT1/ Gp95 antibody for FACS & in-vivo assay

Target products collectionGo to SORT1/SORT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1696-Ab-1/ GM-Tg-hg-MP1696-Ab-2Anti-Human SORT1 monoclonal antibodyHuman
GM-Tg-rg-MP1696-Ab-1/ GM-Tg-rg-MP1696-Ab-2Anti-Rat SORT1 monoclonal antibodyRat
GM-Tg-mg-MP1696-Ab-1/ GM-Tg-mg-MP1696-Ab-2Anti-Mouse SORT1 monoclonal antibodyMouse
GM-Tg-cynog-MP1696-Ab-1/ GM-Tg-cynog-MP1696-Ab-2Anti-Cynomolgus/ Rhesus macaque SORT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1696-Ab-1/ GM-Tg-felg-MP1696-Ab-2Anti-Feline SORT1 monoclonal antibodyFeline
GM-Tg-cang-MP1696-Ab-1/ GM-Tg-cang-MP1696-Ab-2Anti-Canine SORT1 monoclonal antibodyCanine
GM-Tg-bovg-MP1696-Ab-1/ GM-Tg-bovg-MP1696-Ab-2Anti-Bovine SORT1 monoclonal antibodyBovine
GM-Tg-equg-MP1696-Ab-1/ GM-Tg-equg-MP1696-Ab-2Anti-Equine SORT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1696-Ab-1/ GM-Tg-hg-MP1696-Ab-2; GM-Tg-rg-MP1696-Ab-1/ GM-Tg-rg-MP1696-Ab-2;
GM-Tg-mg-MP1696-Ab-1/ GM-Tg-mg-MP1696-Ab-2; GM-Tg-cynog-MP1696-Ab-1/ GM-Tg-cynog-MP1696-Ab-2;
GM-Tg-felg-MP1696-Ab-1/ GM-Tg-felg-MP1696-Ab-2; GM-Tg-cang-MP1696-Ab-1/ GM-Tg-cang-MP1696-Ab-2;
GM-Tg-bovg-MP1696-Ab-1/ GM-Tg-bovg-MP1696-Ab-2; GM-Tg-equg-MP1696-Ab-1/ GM-Tg-equg-MP1696-Ab-2
Products NameAnti-SORT1 monoclonal antibody
Formatmab
Target NameSORT1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SORT1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-298Pre-Made Latozinemab biosimilar, Whole mAb, Anti-SORT1 Antibody: Anti-Gp95/LDLCQ6/NT3/NTR3 therapeutic antibody
    Target AntigenProducts DevelopingMulti-species SORT/ SORT1/ Gp95 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1696
    Target NameSORT1
    Gene ID6272,20661,83576,698310,479915,101090199,511591,100061385
    Gene Symbol and Synonyms2900053A11Rik,Gp95,LDLCQ6,NT3,NTR3,Nts3,Ntsr3,SORT1
    Uniprot AccessionQ99523,O54861
    Uniprot Entry NameSORT_HUMAN,SORT_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index
    DiseaseN/A
    Gene EnsemblENSG00000134243
    Target ClassificationN/A

    The target: SORT1, gene name: SORT1, also named as Gp95, LDLCQ6, NT3, NTR3. This gene encodes a member of the VPS10-related sortilin family of proteins. The encoded preproprotein is proteolytically processed by furin to generate the mature receptor. This receptor plays a role in the trafficking of different proteins to either the cell surface, or subcellular compartments such as lysosomes and endosomes. Expression levels of this gene may influence the risk of myocardial infarction in human patients. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.